IPP Bureau
Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
By IPP Bureau - April 17, 2026
The company allocated €56 million to research and development for next-generation line solutions
Kayentis and RWS partner to improve clinical trial data reliability in CNS studies
By IPP Bureau - April 17, 2026
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Revvity aims to accelerate breakthroughs in cancer research
By IPP Bureau - April 17, 2026
Revvity is positioning its technologies as a connected engine for discovery
Bayer flags major Phase III results for stroke prevention drug asundexian
By IPP Bureau - April 17, 2026
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development
By IPP Bureau - April 17, 2026
Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines
NIFTY Pharma shows stable trend amid cautious market sentiment
By IPP Bureau - April 17, 2026
Muted movement reflects consolidation phase as investors await earnings triggers
DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia
By IPP Bureau - April 17, 2026
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
OpenAI unveils GPT-Rosalind to accelerate drug discovery for pharma giants
By IPP Bureau - April 17, 2026
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
Inter-ministerial study to track zoonotic spillover risks in India
By IPP Bureau - April 17, 2026
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
India pushes policy action on adolescent nutrition as obesity concerns rise
By IPP Bureau - April 17, 2026
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
By IPP Bureau - April 17, 2026
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
ACC Asia 2026 to spotlight next-gen cardiovascular care across Asia-Pacific
By IPP Bureau - April 17, 2026
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
Burnett Homoeopathy hosts global summit at British parliament, amplifies India’s healthcare voice
By IPP Bureau - April 17, 2026
4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration
Moberg Pharma reports 2025 annual results, maintains strong cash position
By IPP Bureau - April 17, 2026
The company reported net revenue of SEK 13.5 million for the full year 2025
Experts push for preventive, equitable haemophilia care at IHC X Summit
By IPP Bureau - April 17, 2026
The national platform brought together healthcare professionals, patient advocates, and stakeholders
